Agenda Topics- Cancer Mutational Profiling: Development of Tools Drives Discovery and Translational Applications
- Epigenetics and Pluripotency
- Epigenetics-based Biomarkers and Potential for Therapeutic Targeting in Cancer
- microRNAs Signatures as Molecular Biomarkers
- Next-Generation Sequencing [NGS]: Its Impact in Research and Clinical Diagnostics
- Opportunities for Companion Diagnostics Development Deploying Genomics Biomarkers
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Confirmed Speakers to date , , Swaine Chen, Assistant Professor, National University of Singapore Ong Choon Kiat, Senior Scientist, National Cancer Centre Singapore Melissa Fullwood, Assistant Professor, Yale-NUS College Jonathan Yuin-Han Loh, Principal Investigator, Institute of Molecular and Cell Biology A*STAR Hidewaki Nakagawa, Laboratory Head, RIKEN Center for Integrated Medical Sciences Enal Razvi, Managing Director, Select Biosciences Inc Richie Soong, Senior Principle Investigator, National University of Singapore Clare Stirzaker, Group Leader, Garvan Institute of Medical Research Andrei Thomas-Tikhonenko, Professor, University of Pennsylvania WEE Zhen Ning Adrian, Postdoctoral Fellow, Genome Institute of Singapore
|